Cubist Systematic Strategies, LLC Atreca, Inc. Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $10,135 - $21,115	-6,497 Reduced 34.04%	12,587 $23,000
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $31,617 - $102,117	-19,638 Reduced 50.72%	19,084 $60,000
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $13,839 - $30,330	-4,822 Reduced 11.07%	38,722 $117,000
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $152,917 - $282,476	-31,144 Reduced 41.7%	43,544 $271,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $13.8 $584,060 - $1.03 Million	74,688 New	74,688 $636,000
Q3 2019 Nov 14, 2019	SELL	$10.42 - $22.04 $58,466 - $123,666	-5,611 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.07 - $18.84 $95,779 - $105,711	5,611 New	5,611 $106,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.